Epilepsy

The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as well as epilepsy may prove its viability as a biomarker of disease pathology, according to data.

LOS ANGELES — Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show.

The average wait time between a referral and neurologist visit was more than a month among older adults, with longer wait times for those with serious neurodegenerative conditions like MS, epilepsy and Parkinson’s disease, new research shows.

LOS ANGELES — The ability to utilize more detailed imaging options, as well as to use certain imaging concurrently to detect epileptogenic lesions during presurgical consultation, may lead to better outcomes for patients, according to a speaker.

LOS ANGELES — For young people with epilepsy, wearable devices may be a feasible method for tracking the effects of antiseizure medications on the autonomic nervous system, according to a presenter.

LOS ANGELES — Patients in Asia, Oceania, Latin America and Africa faced more barriers to genetic testing for epilepsy than those of other regions, which may complicate test interpretations in diverse populations, according to a presenter.

LOS ANGELES — Patients with epilepsy aged 16 to 26 years had a higher frequency of comorbid mood disorders compared with the general epilepsy population, underscoring a need to increase psychiatric screening, data show.

LOS ANGELES — A novel automated data-extraction tool successfully tracked daily antiseizure medication changes for individuals requiring long-term monitoring for epilepsy, data show.

LOS ANGELES — Researchers used data-driven modeling techniques to identify variables that significantly impact pre-surgical consultations for patients with epilepsy, which could lead to more streamlined service by health care providers.